Intuitive Surgical, Inc. (NASDAQ:ISRG) Insider Jamie Samath Sells 22,903 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Jamie Samath also recently made the following trade(s):

• On Monday, November 11th, Jamie Samath sold 269 shares of Intuitive Surgical stock. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $537.80 on Friday. The company has a market capitalization of $191.55 billion, a price-to-earnings ratio of 86.46, a PEG ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $291.39 and a 1 year high of $544.38. The company’s 50 day simple moving average is $496.95 and its 200 day simple moving average is $455.65.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently commented on ISRG. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Mizuho upped their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Finally, Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Institutional Trading of Intuitive Surgical

A number of hedge funds have recently added to or reduced their stakes in the business. Creekmur Asset Management LLC lifted its holdings in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC purchased a new position in Intuitive Surgical during the second quarter worth approximately $26,000. Delos Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the last quarter. Godsey & Gibb Inc. boosted its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. Finally, LRI Investments LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.